Details for Patent: 9,844,558
✉ Email this page to a colleague
Summary for Patent: 9,844,558
Title: | Methods of reducing risk of preterm birth |
Abstract: | This disclosure generally relates to methods for reducing the risk of preterm birth in a pregnant human female patient that include subcutaneous administration of HPC. The disclosure relates in part to the discovery that subcutaneous administration of HPC is actually feasible and can result in sufficient plasma levels of HPC in pregnant patients that can reduce the risk of preterm birth. |
Inventor(s): | Birch; Robert (Saint Charles, MO), Jozwiakowski; Michael J. (Sudbury, MA) |
Assignee: | AMAG Pharmaceuticals, Inc. (Waltham, MA) |
Application Number: | 15/373,262 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,844,558 |
Patent Claim Types: see list of patent claims | Use; Formulation; Delivery; |
Drugs Protected by US Patent 9,844,558
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |